Artificial intelligence for decision support in surgical oncology - a systematic review
Martin Wagner,André Schulze,Michael Haselbeck-Köbler,Pascal Probst,Johanna M. Brandenburg,Eva Kalkum,Ali Majlesara,Ali Ramouz,Rosa Klotz,Felix Nickel,Keno März,Sebastian Bodenstedt,Martin Dugas,Lena Maier-Hein,Arianeb Mehrabi,Stefanie Speidel,Markus W. Büchler,Beat Peter Müller-Stich
DOI: https://doi.org/10.20517/ais.2022.21
2022-09-24
Artificial Intelligence Surgery
Abstract:Aim: We systematically review current clinical applications of artificial intelligence (AI) that use machine learning (ML) methods for decision support in surgical oncology with an emphasis on clinical translation. Methods: MEDLINE, Web of Science, and CENTRAL were searched on 19 January 2021 for a combination of AI and ML-related terms, decision support, and surgical procedures for abdominal malignancies. Data extraction included study characteristics, description of algorithms and their respective purpose, and description of key steps for scientific validation and clinical translation. Results: Out of 8302 articles, 107 studies were included for full-text analysis. Most of the studies were conducted in a retrospective setting (n = 105, 98%), with 45 studies (42%) using data from multiple centers. The most common tumor entities were colorectal cancer (n = 35, 33%), liver cancer (n = 21, 20%), and gastric cancer (n = 17, 16%). The most common prediction task was survival (n = 36, 34%), with artificial neural networks being the most common class of ML algorithms (n = 52, 49%). Key reporting and validation steps included, among others, a complete listing of patient features (n = 95, 89%), training of multiple algorithms (n = 73, 68%), external validation (n = 13, 12%), prospective validation (n = 2, 2%), robustness in terms of cross-validation or resampling (n = 89, 83%), treatment recommendations by ML algorithms (n = 9, 8%), and development of an interface (n = 12, 11%). Conclusion: ML for decision support in surgical oncology is receiving increasing attention with promising results, but robust and prospective clinical validation is mostly lacking. Furthermore, the integration of ML into AI applications is necessary to foster clinical translation.